Top Markets
Coin of the day
Wellnex Life Limited Wellnex Life Limited

Wellnex Life Limited

WNX
Clasificación en acciones #34869
Wellnex Life Limited, together with its subsidiaries, develops, markets, and... Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Precio por acción
$0.06559149
Última sincronización: 2026-08-14
Capitalización bursátil
$4.79M
Cambio (1 día)
1.09%
Cambio (1 año)
-61.95%
País
AU
Comercio Wellnex Life Limited (WNX)
Ganancias de Wellnex Life Limited (WNX)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Wellnex Life Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Wellnex Life Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$2.28B -
US
$961.00M -
US
$485.80M -
US
$133.52M -
US
$93.16M -
SG